BGI Genomics

Minimum Order: 1

Packaging: N/A

Delivery: 15 Days

BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a global network of collaborators.

BGI Genomics is the world’s leading provider of genomic, BGI gene test and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care.

To provide these services, we operate a large network of service Laboratories in China, Hong Kong, the US and Europe. Our customers benefit from the highest level of sequencing experience in the world to support their research and drug discovery projects. Our service laboratories operate under strict internationally recognized quality systems, such as those from CAP and ISO.

More recently, BGI developed and launched its own DNBseq™ sequencing technology, based on DNA Nanoball sequencing technology that was invented in our Complete Genomics research facility in Silicon Valley, California. Scientists around the world now rely on DNBseq NGS services for the highest quality data at the lowest cost.

Country:
Business Type:
Market:
Founded Year:
Address:
Contact:Tommy Ru

*Your name:	Enter name here eg:Ralph zhang
*Your Email:	Enter email here
*To:	BGI Genomics
*Subject:
*Message:
	Enter between 20 to 3,000 characters. English only. Characters : 0 / 3000
*Enter the secure code shown below	Reload Image

		We do inquire for you , please wait ...

Rh factor blood test

Prenatal testing Quick guide to common tests

Prenatal cell-free DNA screening

Prenatal care: 3rd trimester visits

Prenatal care: 2nd trimester visits

Amniocentesis （BGI prenatal test）

Review Amniocentesis is a treatment in which amniotic liquid is eliminated from the womb for testing or treatment. Amniotic fluid is the liquid that borders as well as protects a baby during pregnancy. This liquid includes fetal cells and different healthy proteins. Although ...

BGI Genomics

Human Genome Project What it is and also how it paved the way for personalized medication

During the past century, the scientific area has actually made significant discoveries which played an essential duty in analyzing the human genome: chromosomes were uncovered to be the basis of inheritance; the DNA double helix was seen for the very first time; the organic ...

BGI Genomics

Beijing Genomics Institute (BGI)’s First BGISEQ-500 in Asia Pacific has Settled in Taiwan

Since its publicity at the end of 2015, it has accumulated over 112,000 sample tests, while its analysis is based the clinical data from more than 1.7 million NIFTY/NIFTY PLUS cases worldwide; it is the only NGS analysis system in the world that has substantial clinical gene ...

BGI Genomics

BGI Statement in Response to Reuters Report

SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the company’s non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI’s NIPT tests (one kind of BGI gene test) have been used around the world to identify ...

BGI Genomics

China Genomics Giant Drops Plans for Gene-Edited Pets

China’s largest BGI gene test company is going public. But hold the bacon. Starting this week, investors should be able to buy shares in BGI, China’s largest genomics company, as it completes a $251 million initial public offering. But if you were hoping to get your hands ...

BGI Genomics

BGI is granted patent in 16 countries for non-invasive prenatal genetic test technology

BGI Dx has developed a series of BGI gene test services based on multidisciplinary technologies and approaches, including independent core technologies such as high throughput sequencing, high sensitivity mass spectrum and big data analysis. BGI Dx\'s test product provision ...

BGI Genomics

Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq™ Technology Platform

SAN CARLOS, Calif. and SHENZHEN, China, March 11, 2019 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the largest cell-free DNA clinical testing laboratory in China and one of the ...

BGI Genomics

BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Decline

NEW YORK – Chinese diagnostics firm BGI Genomics reported last week that its H1 2021 revenues declined 11 percent due to decreasing demand for COVID-19 testing. Total revenues were RMB 3.6 billion ($560 million), down from RMB 4.1 billion in the same period last year. The ...

BGI Genomics

BGI Genomics Sees Diagnostics Core Business Rebounding, Overseas Business Growing

NEW YORK – BGI Genomics has seen growth in several areas of its core diagnostic testing business during the first half of 2021 and is working on upgrading its tests in reproductive health. Late last month, the publicly traded clinical BGI gene test and research services arm ...

BGI Genomics